Citadel Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$615M Sell
2,517,800
-51,900
-2% -$12.1M 0.1% 142
2025
Q4
$532M Sell
2,569,700
-525,500
-17% -$104M 0.08% 170
2025
Q3
$574M Buy
3,095,200
+1,013,300
+49% +$174M 0.09% 151
2025
Q2
$318M Sell
2,081,900
-525,700
-20% -$80.8M 0.06% 267
2025
Q1
$432M Buy
2,607,600
+825,400
+46% +$129M 0.08% 160
2024
Q4
$258M Sell
1,782,200
-400,500
-18% -$62.1M 0.04% 309
2024
Q3
$354M Buy
2,182,700
+527,900
+32% +$84.1M 0.07% 204
2024
Q2
$242M Sell
1,654,800
-752,400
-31% -$112M 0.05% 286
2024
Q1
$381M Sell
2,407,200
-741,000
-24% -$118M 0.07% 184
2023
Q4
$493M Sell
3,148,200
-1,264,300
-29% -$194M 0.1% 111
2023
Q3
$687M Buy
4,412,500
+1,765,900
+67% +$291M 0.15% 67
2023
Q2
$438M Sell
2,646,600
-419,800
-14% -$67.8M 0.09% 109
2023
Q1
$475M Buy
3,066,400
+344,000
+13% +$55.5M 0.1% 101
2022
Q4
$481M Sell
2,722,400
-103,800
-4% -$17.9M 0.11% 111
2022
Q3
$462M Buy
2,826,200
+767,400
+37% +$130M 0.11% 106
2022
Q2
$365M Sell
2,058,800
-41,400
-2% -$7.38M 0.09% 133
2022
Q1
$372M Buy
2,100,200
+706,200
+51% +$120M 0.08% 160
2021
Q4
$238M Sell
1,394,000
-595,100
-30% -$97.4M 0.05% 287
2021
Q3
$321M Buy
1,989,100
+77,800
+4% +$13.3M 0.07% 196
2021
Q2
$315M Sell
1,911,300
-474,700
-20% -$78.6M 0.07% 183
2021
Q1
$392M Sell
2,386,000
-573,900
-19% -$92.9M 0.1% 125
2020
Q4
$466M Buy
2,959,900
+1,078,600
+57% +$159M 0.12% 97
2020
Q3
$280M Sell
1,881,300
-74,700
-4% -$11.1M 0.08% 125
2020
Q2
$275M Sell
1,956,000
-23,600
-1% -$3.44M 0.1% 109
2020
Q1
$260M Buy
1,979,600
+106,800
+6% +$15.2M 0.12% 95
2019
Q4
$273M Buy
1,872,800
+742,900
+66% +$101M 0.12% 114
2019
Q3
$146M Buy
1,129,900
+46,400
+4% +$6.11M 0.07% 242
2019
Q2
$151M Sell
1,083,500
-443,700
-29% -$61.4M 0.07% 241
2019
Q1
$213M Buy
1,527,200
+383,400
+34% +$51.4M 0.11% 135
2018
Q4
$148M Sell
1,143,800
-141,200
-11% -$19.7M 0.08% 192
2018
Q3
$178M Buy
1,285,000
+333,600
+35% +$44.3M 0.08% 209
2018
Q2
$115M Sell
951,400
-492,600
-34% -$61.5M 0.06% 320
2018
Q1
$185M Buy
1,444,000
+645,900
+81% +$87.3M 0.1% 143
2017
Q4
$112M Buy
798,100
+23,300
+3% +$3.25M 0.07% 294
2017
Q3
$101M Sell
774,800
-89,100
-10% -$11.8M 0.08% 254
2017
Q2
$114M Buy
863,900
+184,600
+27% +$23.5M 0.1% 189
2017
Q1
$84.6M Sell
679,300
-164,700
-20% -$19.7M 0.08% 244
2016
Q4
$97.2M Sell
844,000
-188,300
-18% -$21.8M 0.1% 173
2016
Q3
$122M Buy
1,032,300
+470,200
+84% +$57M 0.12% 117
2016
Q2
$68.2M Sell
562,100
-165,400
-23% -$18.8M 0.08% 232
2016
Q1
$78.7M Buy
727,500
+213,900
+42% +$22.1M 0.1% 175
2015
Q4
$52.8M Sell
513,600
-19,200
-4% -$1.93M 0.06% 368
2015
Q3
$49.7M Sell
532,800
-364,000
-41% -$35.2M 0.05% 443
2015
Q2
$87.4M Buy
896,800
+423,600
+90% +$42.4M 0.08% 279
2015
Q1
$47.6M Sell
473,200
-18,400
-4% -$1.87M 0.05% 510
2014
Q4
$51.4M Sell
491,600
-41,500
-8% -$4.37M 0.05% 461
2014
Q3
$56.8M Buy
533,100
+100,500
+23% +$10.4M 0.06% 361
2014
Q2
$45.3M Sell
432,600
-144,800
-25% -$14.6M 0.05% 424
2014
Q1
$56.7M Sell
577,400
-202,700
-26% -$18.8M 0.07% 357
2013
Q4
$71.4M Buy
780,100
+82,800
+12% +$7.63M 0.09% 234
2013
Q3
$60.4M Buy
697,300
+169,400
+32% +$15.2M 0.09% 239
2013
Q2
$45.3M Buy
+527,900
New +$44.8M 0.08% 289

Other funds holding JNJ

Citadel Advisors's JNJ Position: Q1 2026 in Review

Citadel Advisors increased its Johnson & Johnson (JNJ) stake by 146% in Q1 2026, buying an estimated $267M and bringing the position to 1,930,976 shares worth $472M. The position accounts for 0.08% of the portfolio, ranked #193.

Citadel Advisors first reported a position in JNJ in Q2 2013 and has held it in 49 quarters since. The position peaked at $480M in Q4 2019. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Citadel Advisors held 1,930,976 shares of Johnson & Johnson worth $472M as of Q1 2026.
  • Citadel Advisors bought 1,146,074 Johnson & Johnson shares in Q1 2026, an estimated $267M.
  • Johnson & Johnson made up 0.08% of Citadel Advisors's portfolio in Q1 2026, its #193 holding.
  • Citadel Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 49 quarters since.
  • Citadel Advisors's Johnson & Johnson position peaked at $480M in Q4 2019.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.